These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9404147)

  • 21. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
    Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
    Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats.
    Melman A; Zotova E; Kim M; Arezzo J; Davies K; DiSanto M; Tar M
    BJU Int; 2009 Nov; 104(9):1292-300. PubMed ID: 19389003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proximal diabetic neuropathy.
    Asbury AK
    Ann Neurol; 1977 Sep; 2(3):179-80. PubMed ID: 617563
    [No Abstract]   [Full Text] [Related]  

  • 24. Longitudinal evaluation of memory performance and peripheral neuropathy in the Ins2C96Y Akita mice.
    Choeiri C; Hewitt K; Durkin J; Simard CJ; Renaud JM; Messier C
    Behav Brain Res; 2005 Feb; 157(1):31-8. PubMed ID: 15617768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diabetic amyotrophy. An infrequent form of diabetic neuropathy].
    Soler L; Pou A; Fossas P; Bayes A; Tolosa E; Reixach R; Montserrat L; Ferrer I
    Rev Clin Esp; 1983 Mar; 168(5):361-4. PubMed ID: 6867413
    [No Abstract]   [Full Text] [Related]  

  • 26. [Etiopathogenesis of diabetic neuropathy].
    Gryz EA; Galicka-Latała D; Szczudlik A; Sieradzki J
    Przegl Lek; 2000; 57(12):727-31. PubMed ID: 11398597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis, classification, and pathogenesis of diabetes mellitus.
    Lebovitz HE
    J Clin Psychiatry; 2001; 62 Suppl 27():5-9; discussion 40-1. PubMed ID: 11806489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can diabetic neuropathy be prevented?
    Park TS; Park JH; Baek HS
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S53-6. PubMed ID: 15563981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
    Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
    Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of the NO/cGMP pathway in the fasting and postprandial state in type 1 diabetes mellitus.
    Farkas K; Jermendy G; Herold M; Ruzicska E; Sasvári M; Somogyi A
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):258-63. PubMed ID: 15146372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetes mellitus with atrophy of the mm. interossei of the upper extremities].
    Lazarov G; Bradistilov S
    Vutr Boles; 1985; 24(2):102-6. PubMed ID: 4036087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of diabetic amyotrophy with severe atrophy and weakness of shoulder girdle muscles showing good response to intravenous immune globulin.
    Wada Y; Yanagihara C; Nishimura Y; Oka N
    Diabetes Res Clin Pract; 2007 Jan; 75(1):107-10. PubMed ID: 16781792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An autopsy case with lower motor neuron disease showing a transient-appearance of anti-GM1 antibody and an improvement of conduction block after gamma-globulin administration].
    Kikuchi H; Kawano Y; Dohura K; Kawamura T; Taniwaki T; Yamada T; Kato M; Iwaki T; Kira J
    No To Shinkei; 1999 May; 51(5):455-64. PubMed ID: 10396755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration.
    Skundric DS; Lisak RP
    Exp Diabesity Res; 2003; 4(4):303-12. PubMed ID: 14668051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
    Dave GS; Kalia K
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk factors involved in symmetrical distal diabetic neuropathy].
    Gómez-Viera N; Soto-Lavastida A; Roselló-Silva H; Gómez de Molina-Iglesias M
    Rev Neurol; 2001 May 1-15; 32(9):806-12. PubMed ID: 11424028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proximal diabetic neuropathy--basic clinical aspects].
    Ehler E
    Cesk Neurol Neurochir; 1989 Mar; 52(2):120-3. PubMed ID: 2743452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic amyotrophy coexisting with lumbar disk herniation and stenosis: a case report.
    Cho KT; Kim NH
    Surg Neurol; 2009 Apr; 71(4):496-9; discussion 499. PubMed ID: 18295835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.